Cargando…
Pathobiology of Respiratory Syncytial Virus (RSV)
Autores principales: | Tripp, Ralph A., McNamara, Paul S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565515/ https://www.ncbi.nlm.nih.gov/pubmed/32659977 http://dx.doi.org/10.3390/vaccines8030367 |
Ejemplares similares
-
Respiratory Syncytial Virus (RSV) Update
por: Krilov, Leonard R., et al.
Publicado: (2022) -
Probenecid Inhibits Respiratory Syncytial Virus (RSV) Replication
por: Murray, Jackelyn, et al.
Publicado: (2022) -
Respiratory Syncytial Virus (RSV) Modulation at the Virus-Host Interface Affects Immune Outcome and Disease Pathogenesis
por: Tripp, Ralph A.
Publicado: (2013) -
Transaminase levels reflect disease severity in children ventilated for respiratory syncytial virus (RSV) bronchiolitis
por: Thorburn, Kentigern, et al.
Publicado: (2018) -
Repurposing Probenecid to Inhibit SARS-CoV-2, Influenza Virus, and Respiratory Syncytial Virus (RSV) Replication
por: Tripp, Ralph A., et al.
Publicado: (2022)